DRI Healthcare Trust (DHT-U) - Total Assets
Based on the latest financial reports, DRI Healthcare Trust (DHT-U) holds total assets worth $967.26 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore DRI Healthcare Trust (DHT-U) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
DRI Healthcare Trust - Total Assets Trend (2020–2024)
This chart illustrates how DRI Healthcare Trust's total assets have evolved over time, based on quarterly financial data. See shareholders equity of DRI Healthcare Trust for net asset value and shareholders' equity analysis.
DRI Healthcare Trust - Asset Composition Analysis
Current Asset Composition (December 2024)
DRI Healthcare Trust's total assets of $967.26 Million consist of 0.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.7% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $823.94 Million | 83.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how DRI Healthcare Trust's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see DRI Healthcare Trust market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DRI Healthcare Trust's current assets represent 0.0% of total assets in 2024, a decrease from 100.0% in 2020.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2024, down from 100.0% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 83.0% of total assets, an increase from 0.0% in 2020.
- Asset Diversification: The largest asset category is intangible assets at 83.7% of total assets.
DRI Healthcare Trust Competitors by Total Assets
Key competitors of DRI Healthcare Trust based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Almirall S.A.
MC:ALM
|
Spain | €2.36 Billion |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
China | CN¥8.25 Billion |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
|
China | CN¥1.41 Billion |
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
USA | $1.44 Billion |
|
North China Pharmaceutical Co Ltd
SHG:600812
|
China | CN¥21.45 Billion |
DRI Healthcare Trust - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.36 | 5.80 | 33.38 |
| Quick Ratio | 1.36 | 5.84 | 33.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $26.08 Million | $124.48 Million | $140.91 Million |
DRI Healthcare Trust - Advanced Valuation Insights
This section examines the relationship between DRI Healthcare Trust's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.16 |
| Latest Market Cap to Assets Ratio | 0.60 |
| Asset Growth Rate (YoY) | 18.0% |
| Total Assets | $984.87 Million |
| Market Capitalization | $593.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values DRI Healthcare Trust's assets below their book value (0.60x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: DRI Healthcare Trust's assets grew by 18.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for DRI Healthcare Trust (2020–2024)
The table below shows the annual total assets of DRI Healthcare Trust from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $984.87 Million | +17.95% |
| 2023-12-31 | $834.96 Million | +31.82% |
| 2022-12-31 | $633.42 Million | +45.05% |
| 2021-12-31 | $436.69 Million | +4366949900.00% |
| 2020-12-31 | $10.00 | -- |
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.